Jacques Young spends much of his time researching Internal medicine, Endocrinology, Kallmann syndrome, Genetics and Hormone. He performs multidisciplinary study in Internal medicine and Congenital Hypogonadotropic Hypogonadism in his work. His studies deal with areas such as Mutation and Neuroactive steroid as well as Endocrinology.
His study in Kallmann syndrome is interdisciplinary in nature, drawing from both Anosmia and Isolated hypogonadotropic hypogonadism. His Hormone research incorporates elements of Cortisol secretion and Hyperplasia. His studies examine the connections between Testosterone and genetics, as well as such issues in Androgen, with regards to Gonadotropin.
His scientific interests lie mostly in Internal medicine, Endocrinology, Context, Congenital Hypogonadotropic Hypogonadism and Kallmann syndrome. His work on Internal medicine is being expanded to include thematically relevant topics such as Mutation. Hypogonadotropic hypogonadism, Gonadotropin, Testosterone, Androgen and Gonadotropin secretion are the core of his Endocrinology study.
Jacques Young integrates Context with Retrospective cohort study in his research. Jacques Young conducted interdisciplinary study in his works that combined Congenital Hypogonadotropic Hypogonadism and Gonadotropin-releasing hormone. His Kallmann syndrome study incorporates themes from Anosmia and Isolated hypogonadotropic hypogonadism.
Jacques Young mainly focuses on Internal medicine, Endocrinology, Missense mutation, Context and Bioinformatics. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Exome. In his papers, Jacques Young integrates diverse fields, such as Endocrinology and Congenital Hypogonadotropic Hypogonadism.
His study in Missense mutation is interdisciplinary in nature, drawing from both Signal transduction and Glucocorticoid receptor. His Bioinformatics research includes elements of Exome sequencing, Gene, Etiology and Gene mutation. His research in Hypogonadotropic hypogonadism intersects with topics in Testosterone and Gonadotropin-releasing hormone.
Endocrinology, Internal medicine, Mutation, Exome sequencing and Genetics are his primary areas of study. His research in the fields of Prolactin overlaps with other disciplines such as Context. Jacques Young has included themes like Testosterone, Receptor and Gonadotropin secretion, Luteinizing hormone in his Prolactin study.
His Hyperplasia and Hypogonadotropic hypogonadism study in the realm of Internal medicine interacts with subjects such as Expert opinion, Multidisciplinary approach and Fertility. His studies in Exome sequencing integrate themes in fields like Sanger sequencing and In silico. His study looks at the relationship between In silico and topics such as Autophagy, which overlap with Infertility and Bioinformatics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.
Catherine Dodé;Jacqueline Levilliers;Jean-Michel Dupont;Anne De Paepe.
Nature Genetics (2003)
Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment
Ulrich Boehm;Pierre Marc Bouloux;Mehul T. Dattani;Nicolas De Roux.
Nature Reviews Endocrinology (2015)
A Family with Hypogonadotropic Hypogonadism and Mutations in the Gonadotropin-Releasing Hormone Receptor
N de Roux;J Young;M Misrahi;R Genet.
The New England Journal of Medicine (1997)
Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
Catherine Dodé;Luis Teixeira;Jacqueline Levilliers;Corinne Fouveaut.
PLOS Genetics (2005)
Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and Its Precursors in the Brain, Plasma, and Steroidogenic Glands of Male and Female Rats
C Corpéchot;J Young;M Calvel;C Wehrey.
Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus.
M Vallée;W Mayo;M Darnaudéry;C Corpéchot.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Isolated Familial Hypogonadotropic Hypogonadism and a GNRH1 Mutation
Jérôme Bouligand;Cristina Ghervan;Javier A. Tello;Sylvie Brailly-Tabard.
The New England Journal of Medicine (2009)
Large genomic rearrangements in the hepatocyte nuclear factor-1β (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5
Christine Bellanné-Chantelot;Séverine Clauin;Dominique Chauveau;Philippe Collin.
Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 Are Identified in Individuals with Congenital Hypogonadotropic Hypogonadism
Hichem Miraoui;Andrew A. Dwyer;Andrew A. Dwyer;Gerasimos P. Sykiotis;Gerasimos P. Sykiotis;Lacey Plummer.
American Journal of Human Genetics (2013)
The Postmenopausal Ovary Is Not a Major Androgen-Producing Gland
Beatrice Couzinet;Geri Meduri;Maria G. Lecce;Jacques Young.
The Journal of Clinical Endocrinology and Metabolism (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: